Publication:
Using Predictive Analytics to Identify Drug-Resistant Epilepsy Patients

dc.authorscopusid55887961100
dc.authorscopusid57189870930
dc.authorscopusid6504418003
dc.authorscopusid8639397400
dc.authorscopusid57215881551
dc.contributor.authorDelen, D.
dc.contributor.authorDavazdahemami, B.
dc.contributor.authorEryarsoy, E.
dc.contributor.authorTomak, L.
dc.contributor.authorValluru, A.
dc.date.accessioned2020-06-21T12:18:14Z
dc.date.available2020-06-21T12:18:14Z
dc.date.issued2020
dc.departmentOndokuz Mayıs Üniversitesien_US
dc.department-temp[Delen] Dursun, Oklahoma State University, Stillwater, OK, United States; [Davazdahemami] Behrooz, University of Wisconsin, Walnut, WI, United States; [Eryarsoy] Enes, İstanbul Şehir Üniversitesi, Istanbul, Turkey; [Tomak] Leman, Ondokuz Mayis Üniversitesi, Samsun, Turkey; [Valluru] Abhinav, Oklahoma State University, Stillwater, OK, United Statesen_US
dc.description.abstractEpilepsy is one of the most common brain disorders that greatly affects patients’ quality of life and poses serious risks to their health. While the majority of the patients positively respond to the existing anti-epilepsy drugs, others who developed the refractory type of epilepsy show resistance against drug therapy and need to undergo advance treatments such as surgery. Given that identifying such patients is not a straightforward process and requires long courses of trial and error with anti-epilepsy drugs, this study aims at predicting those at-risk patients using clinical and demographic data obtained from electronic medical records. Specifically, the study employs several predictive analytics machine-learning methods, equipped with a novel approach for data balancing, to identify drug-resistant patients using their comorbidities and demographic information along with the initial epilepsy-related diagnosis made by their physician. The promising results we obtained highlight the potential use of machine-learning techniques in facilitating medical decisions and suggest the possibility of extending the proposed approach for developing a clinical decision support system for medical professionals. © The Author(s) 2019.en_US
dc.identifier.doi10.1177/1460458219833120
dc.identifier.endpage460en_US
dc.identifier.issn1460-4582
dc.identifier.issn1741-2811
dc.identifier.issue1en_US
dc.identifier.pmid30859886
dc.identifier.scopus2-s2.0-85082236927
dc.identifier.scopusqualityQ1
dc.identifier.startpage449en_US
dc.identifier.urihttps://doi.org/10.1177/1460458219833120
dc.identifier.volume26en_US
dc.identifier.wosWOS:000532778400033
dc.identifier.wosqualityQ2
dc.language.isoenen_US
dc.publisherSAGE Publications Ltd info@sagepub.co.uken_US
dc.relation.ispartofHealth Informatics Journalen_US
dc.relation.journalHealth Informatics Journalen_US
dc.relation.publicationcategoryMakale - Uluslararası Hakemli Dergi - Kurum Öğretim Elemanıen_US
dc.rightsinfo:eu-repo/semantics/openAccessen_US
dc.subjectAnti-Epileptic Drugsen_US
dc.subjectDrug Resistanceen_US
dc.subjectEpilepsyen_US
dc.subjectMachine Learningen_US
dc.subjectPredictive Analyticsen_US
dc.subjectRefractory Epilepsyen_US
dc.titleUsing Predictive Analytics to Identify Drug-Resistant Epilepsy Patientsen_US
dc.typeArticleen_US
dspace.entity.typePublication

Files